Patent classifications
A61K36/68
DIETARY FIBER COMPOSITIONS
The present disclosure relates to compositions comprising dietary fibers. For example, in some embodiments, the composition comprises two or more fibers (e.g., fibers such as beta-glucan, wheat dextrin, inulin, pectin, psyllium, or potato starch) each present in amount of about 40% to about 60% w/w of the composition. In some embodiments, the composition further includes a sweetener and/or a flavoring agent. Such compositions are useful in the treatment or improvement of gastrointestinal diseases.
DIETARY FIBER COMPOSITIONS
The present disclosure relates to compositions comprising dietary fibers. For example, in some embodiments, the composition comprises two or more fibers (e.g., fibers such as beta-glucan, wheat dextrin, inulin, pectin, psyllium, or potato starch) each present in amount of about 40% to about 60% w/w of the composition. In some embodiments, the composition further includes a sweetener and/or a flavoring agent. Such compositions are useful in the treatment or improvement of gastrointestinal diseases.
DIETARY FIBER COMPOSITIONS
The present disclosure relates to compositions comprising dietary fibers. For example, in some embodiments, the composition comprises two or more fibers (e.g., fibers such as beta-glucan, wheat dextrin, inulin, pectin, psyllium, or potato starch) each present in amount of about 40% to about 60% w/w of the composition. In some embodiments, the composition further includes a sweetener and/or a flavoring agent. Such compositions are useful in the treatment or improvement of gastrointestinal diseases.
PROCESS FOR PRODUCING ENRICHED FRACTION FROM BACOPA MONNIERI EXTRACT FOR MANAGEMENT OF NEURODEGENERATIVE DISORDERS
The present invention is the process of preparing enriched fraction of Bacopa monnieri extract Bacosane. Bacopa monnieri extract Bacosane is chemically standardized with 8 different bioactive compounds. The 8 bioactive compounds are asiatic acid, ebelin lactone, Bacogenin A1, bhramic acid, Bacoside A3, Bacopaside 1, Bacopaside 2 and jujubogenin. The process of preparing the Bacopa monnieri extract Bacosane is carried by extraction with ethanol, concentration, water washing, layer separation, extraction with ethyl acetate, concentration of ethyl acetate layer, water addition or IPA washing, spray drying or vacuum drying, milling, sieving, blending and packing of the resultant Bacopa monnieri extract Bacosane.
Taste masking formulation for bitter natural compounds
The invention discloses taste masking formulations for bitter natural compounds, selected from the extracts, fraction and pure phytochemicals produced in combination with a synthetic polymer or a natural polymer. The invention also relates to the novel process of producing the taste masking formulations. The invention also relates to taste masking formulations of Bacopa extracts with no bitter taste or negligible bitter taste in combination with synthetic polymers such as Eudragit or natural polymers such as Shellac.
Taste masking formulation for bitter natural compounds
The invention discloses taste masking formulations for bitter natural compounds, selected from the extracts, fraction and pure phytochemicals produced in combination with a synthetic polymer or a natural polymer. The invention also relates to the novel process of producing the taste masking formulations. The invention also relates to taste masking formulations of Bacopa extracts with no bitter taste or negligible bitter taste in combination with synthetic polymers such as Eudragit or natural polymers such as Shellac.
PSYLLIUM HUSK GRANULE, METHOD FOR PRODUCING SAME, AND POWDERED DRINK CONTAINING PSYLLIUM HUSK GRANULE
The purpose of the present invention is to provide a psyllium husk granule whose affinity for water is significantly improved, and a method for producing the psyllium husk granule. In addition, the purpose of the present invention is to provide a powdered drink in which the psyllium husk granule is used. The psyllium husk granule is obtained by performing granulation using powdered sugar which has passed through a 120 to 280-mesh Tyler screen. The method for producing the psyllium husk granule comprises fluidizing a mixture containing a psyllium husk and powdered sugar which has passed through a 120 to 280-mesh Tyler screen, then spraying water, and finally drying the mixture for granulation.
PSYLLIUM HUSK GRANULE, METHOD FOR PRODUCING SAME, AND POWDERED DRINK CONTAINING PSYLLIUM HUSK GRANULE
The purpose of the present invention is to provide a psyllium husk granule whose affinity for water is significantly improved, and a method for producing the psyllium husk granule. In addition, the purpose of the present invention is to provide a powdered drink in which the psyllium husk granule is used. The psyllium husk granule is obtained by performing granulation using powdered sugar which has passed through a 120 to 280-mesh Tyler screen. The method for producing the psyllium husk granule comprises fluidizing a mixture containing a psyllium husk and powdered sugar which has passed through a 120 to 280-mesh Tyler screen, then spraying water, and finally drying the mixture for granulation.
Phytotherapeutic product for correction of symptom-complex of fibrocystic changes of mammary gland
A phytotherapeutic product for treatment of fibrocystic changes of mammary gland.
Phytotherapeutic product for correction of symptom-complex of fibrocystic changes of mammary gland
A phytotherapeutic product for treatment of fibrocystic changes of mammary gland.